Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE40.3400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots35.0000/ 1
- Ask / Lots64.1400/ 1
- Open / Previous Close0.0000 / 40.3400
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 1707 | 40.29 |
| 09:38 ET | 100 | 40.245 |
| 09:39 ET | 200 | 40.22 |
| 09:41 ET | 4931 | 39.715 |
| 09:43 ET | 400 | 39.78 |
| 09:45 ET | 100 | 39.785 |
| 09:50 ET | 300 | 39.85 |
| 09:52 ET | 4576 | 39.86 |
| 09:54 ET | 1496 | 39.965 |
| 09:56 ET | 500 | 40.19 |
| 09:57 ET | 305 | 40 |
| 09:59 ET | 100 | 40 |
| 10:03 ET | 325 | 40.15 |
| 10:08 ET | 1800 | 40.14 |
| 10:10 ET | 100 | 40.1 |
| 10:12 ET | 400 | 40.09 |
| 10:14 ET | 100 | 40.13 |
| 10:15 ET | 100 | 40.08 |
| 10:19 ET | 300 | 40.08 |
| 10:24 ET | 200 | 40.08 |
| 10:26 ET | 300 | 40.02 |
| 10:28 ET | 300 | 40.08 |
| 10:30 ET | 300 | 40 |
| 10:32 ET | 160 | 39.94 |
| 10:33 ET | 100 | 40 |
| 10:37 ET | 600 | 40.12 |
| 10:39 ET | 100 | 40.05 |
| 10:42 ET | 96800 | 40.215 |
| 10:46 ET | 100 | 40.29 |
| 10:48 ET | 215 | 40.29 |
| 10:50 ET | 300 | 40.12 |
| 10:51 ET | 3200 | 40.225 |
| 10:53 ET | 400 | 40.28 |
| 10:57 ET | 421 | 40.28 |
| 11:00 ET | 1247 | 40.06 |
| 11:04 ET | 348 | 40 |
| 11:06 ET | 400 | 40.065 |
| 11:09 ET | 1500 | 40.14 |
| 11:13 ET | 100 | 40.17 |
| 11:18 ET | 200 | 40.1 |
| 11:22 ET | 725 | 40.2 |
| 11:24 ET | 100 | 40.185 |
| 11:27 ET | 2200 | 40.12 |
| 11:31 ET | 100 | 40.1 |
| 11:33 ET | 3817 | 40.19 |
| 11:36 ET | 340 | 40.165 |
| 11:38 ET | 200 | 40.18 |
| 11:42 ET | 100 | 40.2 |
| 11:44 ET | 600 | 40.16 |
| 11:49 ET | 400 | 40.11 |
| 11:51 ET | 300 | 40.13 |
| 11:54 ET | 700 | 40.17 |
| 11:56 ET | 200 | 40.19 |
| 11:58 ET | 100 | 40.22 |
| 12:00 ET | 400 | 40.18 |
| 12:02 ET | 700 | 40.135 |
| 12:03 ET | 1300 | 40.16 |
| 12:05 ET | 100 | 40.155 |
| 12:07 ET | 100 | 40.155 |
| 12:09 ET | 1132 | 40.205 |
| 12:12 ET | 1300 | 40.18 |
| 12:14 ET | 900 | 40.21 |
| 12:16 ET | 300 | 40.225 |
| 12:18 ET | 1200 | 40.205 |
| 12:21 ET | 1291 | 40.17 |
| 12:25 ET | 100 | 40.19 |
| 12:27 ET | 1200 | 40.2 |
| 12:30 ET | 1400 | 40.18 |
| 12:32 ET | 100 | 40.19 |
| 12:36 ET | 200 | 40.18 |
| 12:38 ET | 1800 | 40.19 |
| 12:39 ET | 2000 | 40.33 |
| 12:41 ET | 1704 | 40.36 |
| 12:43 ET | 600 | 40.29 |
| 12:48 ET | 200 | 40.28 |
| 12:50 ET | 190 | 40.315 |
| 12:54 ET | 100 | 40.31 |
| 12:56 ET | 1071 | 40.29 |
| 12:57 ET | 600 | 40.23 |
| 12:59 ET | 200 | 40.23 |
| 01:01 ET | 20379 | 40.305 |
| 01:03 ET | 800 | 40.27 |
| 01:06 ET | 200 | 40.295 |
| 01:08 ET | 2400 | 40.31 |
| 01:12 ET | 65907 | 40.5 |
| 01:14 ET | 100 | 40.565 |
| 01:15 ET | 16905 | 40.59 |
| 01:17 ET | 400 | 40.595 |
| 01:19 ET | 100 | 40.595 |
| 01:21 ET | 500 | 40.595 |
| 01:24 ET | 300 | 40.595 |
| 01:28 ET | 200 | 40.6 |
| 01:33 ET | 100 | 40.6 |
| 01:37 ET | 100 | 40.61 |
| 01:44 ET | 936 | 40.61 |
| 01:46 ET | 132 | 40.61 |
| 01:48 ET | 100 | 40.62 |
| 01:50 ET | 100 | 40.62 |
| 01:51 ET | 1400 | 40.595 |
| 01:53 ET | 700 | 40.51 |
| 01:55 ET | 200 | 40.52 |
| 01:57 ET | 358 | 40.585 |
| 02:00 ET | 100 | 40.585 |
| 02:02 ET | 1400 | 40.49 |
| 02:04 ET | 1800 | 40.535 |
| 02:08 ET | 200 | 40.55 |
| 02:09 ET | 100 | 40.51 |
| 02:11 ET | 100 | 40.51 |
| 02:13 ET | 700 | 40.52 |
| 02:15 ET | 1800 | 40.5 |
| 02:18 ET | 800 | 40.53 |
| 02:20 ET | 100 | 40.535 |
| 02:22 ET | 200 | 40.55 |
| 02:24 ET | 2564 | 40.59 |
| 02:26 ET | 358 | 40.705 |
| 02:27 ET | 300 | 40.73 |
| 02:31 ET | 552 | 40.68 |
| 02:38 ET | 600 | 40.72 |
| 02:42 ET | 500 | 40.69 |
| 02:44 ET | 1200 | 40.69 |
| 02:45 ET | 596 | 40.68 |
| 02:47 ET | 715 | 40.73 |
| 02:49 ET | 1406 | 40.65 |
| 02:51 ET | 299 | 40.66 |
| 02:54 ET | 200 | 40.67 |
| 02:56 ET | 300 | 40.65 |
| 02:58 ET | 100 | 40.69 |
| 03:00 ET | 500 | 40.65 |
| 03:02 ET | 200 | 40.64 |
| 03:03 ET | 400 | 40.62 |
| 03:05 ET | 300 | 40.62 |
| 03:07 ET | 400 | 40.62 |
| 03:09 ET | 100 | 40.59 |
| 03:12 ET | 2664 | 40.76 |
| 03:14 ET | 200 | 40.82 |
| 03:16 ET | 200 | 40.85 |
| 03:20 ET | 4021 | 41.005 |
| 03:21 ET | 100 | 41.005 |
| 03:23 ET | 1728 | 41.015 |
| 03:25 ET | 100 | 41.02 |
| 03:27 ET | 300 | 41.05 |
| 03:32 ET | 1200 | 41.07 |
| 03:34 ET | 1400 | 41.02 |
| 03:36 ET | 1754 | 40.85 |
| 03:38 ET | 1836 | 40.87 |
| 03:39 ET | 1787 | 40.69 |
| 03:41 ET | 2293 | 40.61 |
| 03:43 ET | 2901 | 40.5 |
| 03:45 ET | 900 | 40.48 |
| 03:48 ET | 3670 | 40.5 |
| 03:50 ET | 4265 | 40.5 |
| 03:52 ET | 31801 | 40.56 |
| 03:54 ET | 2661 | 40.41 |
| 03:56 ET | 4705 | 40.29 |
| 03:57 ET | 5882 | 40.23 |
| 03:59 ET | 8491 | 40.34 |
May 10, 2024
DJ Xenon Pharmaceuticals Is Maintained at Buy by Needham, from 6:12PM ET on Friday May 10, 2024 by Dow Jones
6:12PM ET on Friday May 10, 2024 by Dow JonesDJ Xenon Pharmaceuticals Is Maintained at Buy by Citigroup, from 5:48PM ET on Friday May 10, 2024 by Dow Jones
5:48PM ET on Friday May 10, 2024 by Dow JonesDJ Xenon Pharmaceuticals Is Maintained at Outperform by Wedbush, from 9:30AM ET on Friday May 10, 2024 by Dow Jones
9:30AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow Jones*DJ Xenon Pharmaceuticals 1Q Loss/Shr 62c >XENE, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 3.0B | -14.9x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Apogee Therapeutics Inc | 3.1B | -30.9x | --- |
Summit Therapeutics Inc | 3.2B | -2.9x | --- |
Iovance Biotherapeutics Inc | 2.9B | -5.7x | --- |
IDEAYA Biosciences Inc | 3.1B | -20.8x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.0B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.23 |
EPS | $-2.71 |
Book Value | $12.31 |
P/E Ratio | -14.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
